Litcius/Paper detail

Structure-based drug design of an inhibitor of the SARS-CoV-2 (COVID-19) main protease using free software: A tutorial for students and scientists

Sheng Zhang, Maj Krumberger, Michael A. Morris, Chelsea Marie T. Parrocha, Adam G. Kreutzer, James S. Nowick

2021European Journal of Medicinal Chemistry48 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)ChemistryAutoDockPeptideSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Docking (animal)SoftwareProteaseAntiviral drugCoronavirusComputational biologyComputer scienceDrugBiochemistryEnzymePharmacologyProgramming languageBiologyMedicineInfectious disease (medical specialty)NursingPathologyGeneIn silicoDiseaseComputational Drug Discovery MethodsSynthesis and biological activityClick Chemistry and Applications
Structure-based drug design of an inhibitor of the SARS-CoV-2 (COVID-19) main protease using free software: A tutorial for students and scientists | Litcius